Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin
PHASE3CompletedINTERVENTIONAL
Enrollment
144
Participants
Timeline
Start Date
October 31, 2005
Study Completion Date
February 28, 2009
Conditions
Chronic Hepatitis C
Interventions
DRUG
Paroxetine
Trial Locations (1)
54500
Service d'Hépato-gastroentérologie CHU de Nancy, Vandœuvre-lès-Nancy
All Listed Sponsors
lead
French National Agency for Research on AIDS and Viral Hepatitis
OTHER_GOV
NCT00196664 - Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin | Biotech Hunter | Biotech Hunter